Baxter Healthcare Corporation: Vasopressin, In 0.9% Sodium Chloride Injection, 20 Units Per
Baxter Healthcare is recalling Vasopressin injection (a medication used to treat low blood pressure) in 100mL vials due to manufacturing process deviations that don't meet FDA standards. The affected product was distributed nationwide across the U.S., Puerto Rico, and Chile. This is a Class II recall, meaning the product could potentially cause adverse health effects.
- Recalling firm
- Baxter Healthcare Corporation
- Product
- Vasopressin, in 0.9% Sodium Chloride Injection, 20 units per 100 mL (0.2 units/mL), 100mL Single-Dose Container, Rx only, Sterile, Baxter Healthcare Corporation, Deerfield, IL, 60012 USA, NDC 0338-9640-12.
- Reason
- CGMP Deviations
- Classification
- Class II
- Category
- drug recall
- Country
- United States
- Agency
- U.S. Food and Drug Administration
- Recall date
- 2026-08-06
- Status
- Ongoing
- Areas affected
- AL, AK, AZ, AR, CA, CO, CT, DE, FL, GA, HI, ID, ...
- Distribution
- US Nationwide; Puerto Rico; and Chile.
Official recall notice from U.S. Food and Drug Administration
Recall details on Nibble Recalls: https://trynibble.app/recalls/122c0ec8-c561-42e7-9b5e-b59fb7340a26